ChronoScale Holdings Statistics
Total Valuation
CHRN has a market cap or net worth of $2.17 billion. The enterprise value is $2.28 billion.
| Market Cap | 2.17B |
| Enterprise Value | 2.28B |
Important Dates
The last earnings date was Wednesday, October 14, 2026, after market close.
| Earnings Date | Oct 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CHRN has 145.64 million shares outstanding.
| Current Share Class | 145.64M |
| Shares Outstanding | 145.64M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 3.15% |
| Owned by Institutions (%) | 0.93% |
| Float | 1.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 30.26 |
| Forward PS | 19.90 |
| PB Ratio | 12.00 |
| P/TBV Ratio | 17.27 |
| P/FCF Ratio | 177.76 |
| P/OCF Ratio | 55.47 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 85.69, with an EV/FCF ratio of 186.86.
| EV / Earnings | n/a |
| EV / Sales | 31.81 |
| EV / EBITDA | 85.69 |
| EV / EBIT | n/a |
| EV / FCF | 186.86 |
Financial Position
The company has a current ratio of 0.51, with a Debt / Equity ratio of 0.67.
| Current Ratio | 0.51 |
| Quick Ratio | 0.26 |
| Debt / Equity | 0.67 |
| Debt / EBITDA | 2.37 |
| Debt / FCF | 9.89 |
| Interest Coverage | -3.52 |
Financial Efficiency
Return on equity (ROE) is -38.49% and return on invested capital (ROIC) is -7.07%.
| Return on Equity (ROE) | -38.49% |
| Return on Assets (ROA) | -6.70% |
| Return on Invested Capital (ROIC) | -7.07% |
| Return on Capital Employed (ROCE) | -14.12% |
| Weighted Average Cost of Capital (WACC) | 9.48% |
| Revenue Per Employee | $813,682 |
| Profits Per Employee | -$573,102 |
| Employee Count | 86 |
| Asset Turnover | 0.23 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +201.22% in the last 52 weeks. The beta is 0.98, so CHRN's price volatility has been similar to the market average.
| Beta (5Y) | 0.98 |
| 52-Week Price Change | +201.22% |
| 50-Day Moving Average | 20.04 |
| 200-Day Moving Average | 15.58 |
| Relative Strength Index (RSI) | 30.11 |
| Average Volume (20 Days) | 131,702 |
Short Selling Information
The latest short interest is 576,571, so 0.40% of the outstanding shares have been sold short.
| Short Interest | 576,571 |
| Short Previous Month | 701,226 |
| Short % of Shares Out | 0.40% |
| Short % of Float | 44.00% |
| Short Ratio (days to cover) | 4.40 |
Income Statement
In the last 12 months, CHRN had revenue of $71.60 million and -$50.43 million in losses. Loss per share was -$0.36.
| Revenue | 71.60M |
| Gross Profit | -17.09M |
| Operating Income | -33.76M |
| Pretax Income | -49.30M |
| Net Income | -50.43M |
| EBITDA | 26.58M |
| EBIT | -33.76M |
| Loss Per Share | -$0.36 |
Balance Sheet
The company has $9.66 million in cash and $120.56 million in debt, with a net cash position of -$110.90 million or -$0.76 per share.
| Cash & Cash Equivalents | 9.66M |
| Total Debt | 120.56M |
| Net Cash | -110.90M |
| Net Cash Per Share | -$0.76 |
| Equity (Book Value) | 180.03M |
| Book Value Per Share | 1.24 |
| Working Capital | -42.64M |
Cash Flow
In the last 12 months, operating cash flow was $39.07 million and capital expenditures -$26.88 million, giving a free cash flow of $12.19 million.
| Operating Cash Flow | 39.07M |
| Capital Expenditures | -26.88M |
| Depreciation & Amortization | 60.34M |
| Net Borrowing | -89.52M |
| Free Cash Flow | 12.19M |
| FCF Per Share | $0.08 |
Margins
Gross margin is -23.86%, with operating and profit margins of -47.14% and -70.28%.
| Gross Margin | -23.86% |
| Operating Margin | -47.14% |
| Pretax Margin | -68.85% |
| Profit Margin | -70.28% |
| EBITDA Margin | 37.13% |
| EBIT Margin | -47.14% |
| FCF Margin | 17.03% |
Dividends & Yields
CHRN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -2.33% |
| FCF Yield | 0.56% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 280.58% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 2, 2025. It was a reverse split with a ratio of 1:15.
| Last Split Date | Jun 2, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
CHRN has an Altman Z-Score of -0.42 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.42 |
| Piotroski F-Score | 2 |